Attitudes and Perceptions of Corresponding Authors From Top International Medical Journals Regarding the Use of Artificial Intelligence in the Scientific Process (AISurvey6 A+)

December 24, 2025 updated by: Centre Hospitalier Universitaire de Nice
"Artificial intelligence (AI), including large language models and conversational tools, is increasingly being used in medical research. These tools may assist researchers at different stages of the scientific process, such as generating research ideas, reviewing the literature, analyzing data, writing manuscripts, and preparing articles for publication. While interest in AI is growing rapidly, there is still limited information on how these tools are actually perceived and used by leading medical researchers. This study aims to better understand the attitudes, perceptions, and self-reported uses of artificial intelligence among corresponding authors who have published in six major international medical journals. These authors play a key role in shaping scientific standards and editorial practices, and their views are essential to understanding how AI may influence the future of medical research. Participants are invited to complete an anonymous online questionnaire that asks about their familiarity with AI tools, how and when they use or plan to use them in the research process, the potential benefits they perceive, and the concerns or limitations they identify. The survey also explores participants' expectations regarding transparency, ethical guidance, and journal policies related to the use of artificial intelligence in scientific work.The study is observational and does not involve any medical intervention or collection of personal or health-related data. Participation is voluntary, and responses are fully anonymous.

Study Overview

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alpes Maritimes
      • Nice, Alpes Maritimes, France, 06000
        • CHU de Nice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of corresponding authors who have published scientific articles in leading international medical journals. Participants are identified through publicly available publication data from six major journals (The New England Journal of Medicine, The Lancet, JAMA, Nature, Science, and The BMJ) and are invited to participate via professional email addresses. The population includes adult researchers from diverse biomedical and medical disciplines, with no geographic restriction.

Description

Inclusion Criteria:

  • Participants without any disease, condition, or related symptoms are permitted to participate. This study is a non-clinical, observational survey focusing on attitudes and practices related to artificial intelligence in scientific research, not on health conditions.

Exclusion Criteria:

  • Authors who are not corresponding authors.
  • Students, residents, interns, or trainees without corresponding author status.
  • Individuals not involved in biomedical or medical research activities.
  • Individuals who decline to participate or do not complete the online questionnaire.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Authors Survey Group
This label identifies the single cohort of participants, consisting of corresponding authors invited to complete the anonymous online survey. No comparison or control groups are included.
This is an observational, non-interventional study based on an anonymous online questionnaire. No intervention is administered to participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported attitudes regarding the use of artificial intelligence in the scientific research process
Time Frame: At the inclusion
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
At the inclusion
Perceptions regarding the use of artificial intelligence in the scientific research process
Time Frame: At the inclusion
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
At the inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported patterns of use, regarding artificial intelligence tools in scientific research and publishing
Time Frame: At the inclusion
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items. Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
At the inclusion
Perceived benefits regarding artificial intelligence tools in scientific research and publishing
Time Frame: At the inclusion
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items. Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
At the inclusion
Risk regarding artificial intelligence tools in scientific research and publishing
Time Frame: At the inclusion
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items. Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
At the inclusion
Expectations regarding artificial intelligence tools in scientific research and publishing
Time Frame: At the inclusion
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items. Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
At the inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 10, 2025

Primary Completion (Estimated)

March 10, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

December 24, 2025

First Submitted That Met QC Criteria

December 24, 2025

First Posted (Actual)

January 8, 2026

Study Record Updates

Last Update Posted (Actual)

January 8, 2026

Last Update Submitted That Met QC Criteria

December 24, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 25Chirplast02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Artificial Intelligence

Clinical Trials on observational survey

Subscribe